A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1998
11/17/1998	US5837491 Polynucleotides encoding gelonin sequences
11/17/1998	US5837490 Therapeutic, diagnostic, research uses
11/17/1998	US5837488 Cloning and production of human von Willebrand Factor GP1b binding domain polypeptides and methods of using same
11/17/1998	US5837486 Method for preparing soluble analogues of integrins
11/17/1998	US5837479 Gene expression in presence of arachidonic acid; measuring metabolic conversion; evaluation
11/17/1998	US5837478 Cellular adhesion molecules
11/17/1998	US5837477 Hybrid; immunomodulatory properties
11/17/1998	US5837472 Nucleotide sequences coding for a protein with urease activity
11/17/1998	US5837453 Cancer diagnosis
11/17/1998	US5837451 Identifying composition which affect kinase activity
11/17/1998	US5837448 Polynucleotides with specific sequences of amino acids
11/17/1998	US5837443 Genes and colorectal cancer, testing for detection of proteins
11/17/1998	US5837293 Septic or toxic shock treatment
11/17/1998	US5837276 Apparatus for the delivery of elongate solid drug compositions
11/17/1998	US5837265 Chemically-modified clostridiatoxin with improved properties
11/17/1998	US5837262 Pharmaceutical compositions against several herpes virus infections and/or atherosclerotic plaque
11/17/1998	US5837258 Induction of tissue, bone or cartilage formation using connective tissue growth factor
11/17/1998	US5837255 Method of reducing blood glucose by administering Harunganin or Vismin
11/17/1998	US5837251 Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
11/17/1998	US5837248 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
11/17/1998	US5837247 Chemotactic agents for t-cells
11/17/1998	US5837244 Treating a cell proliferative disorder
11/17/1998	US5837243 Therapeutic compounds comprised of anti-Fc receptor antibodies
11/17/1998	US5837242 Multivalent and multispecific binding proteins, their manufacture and use
11/17/1998	US5837241 Method of treating heart failure using leukemia inhibitory factor antagonists optionally with endothelin antagonists
11/17/1998	US5837240 Multimeric, recombinant urease vaccine
11/17/1998	US5837232 Use of an interleukin-10 antagonist to treat a B cell mediated autoimmune disorder
11/17/1998	US5837231 GM-CSF administration for the treatment and prevention of recurrence of brain tumors
11/17/1998	US5837230 Administering macrophage colony stimulating factor
11/17/1998	US5837229 Administering as antitumor and wound healing agents; bone marrow transplants; stimulating monocytes, macrophages, and neutrophils
11/16/1998	CA2205680A1 Clip immunomodulatory peptide
11/13/1998	CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998	WO1998050582A1 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES
11/12/1998	WO1998050567A1 Reagents and methods useful for detecting diseases of the prostate
11/12/1998	WO1998050552A1 Novel tumor antigens
11/12/1998	WO1998050551A1 Rage1-like protein
11/12/1998	WO1998050550A1 Human translocation associated protein
11/12/1998	WO1998050548A1 New vesicle trafficking protein
11/12/1998	WO1998050546A2 B cell receptor associated proteins
11/12/1998	WO1998050545A1 Human smt-3 like protein
11/12/1998	WO1998050544A1 Recombinant fragments of the human acetylcholine receptor and their use for treatment of myasthenia gravis
11/12/1998	WO1998050543A1 Recombinant lactoferrin, methods of production from plants and uses
11/12/1998	WO1998050540A1 MODIFIED ANTISENSE NUCLEOTIDES COMPLEMENTARY TO A SECTION OF THE HUMAN Ha-Ras GENE
11/12/1998	WO1998050536A1 Hmgi proteins in tumors and obesity
11/12/1998	WO1998050534A1 Protease inhibitors
11/12/1998	WO1998050530A2 Enzymatic nucleic acids: synthesis, selection and use
11/12/1998	WO1998050435A1 Immunotoxins, comprising an onc protein, directed against malignant cells
11/12/1998	WO1998050434A1 Methods for eosinophil depletion and compositions therefor
11/12/1998	WO1998050433A2 Human monoclonal antibodies to epidermal growth factor receptor
11/12/1998	WO1998050432A1 Recombinant antibody-enzyme fusion proteins
11/12/1998	WO1998050431A2 A method for making multispecific antibodies having heteromultimeric and common components
11/12/1998	WO1998050430A2 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
11/12/1998	WO1998050428A1 Treatment of osteoporosis
11/12/1998	WO1998050426A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
11/12/1998	WO1998050425A2 Human tsc-22-like proteins
11/12/1998	WO1998050424A2 Human serine protease precursor
11/12/1998	WO1998050422A1 A novel strain of bacillus for controlling plant diseases and corn rootworm
11/12/1998	WO1998050421A1 Analgesic peptidomimetic compounds
11/12/1998	WO1998050420A1 Serine protease inhibitors
11/12/1998	WO1998050406A1 Cell proliferation related genes
11/12/1998	WO1998050402A1 Dna molecule conferring on mycobacterium tuberculosis resistance against antimicrobial reactive oxygen and nitrogen intermediates
11/12/1998	WO1998050079A2 Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes
11/12/1998	WO1998050076A1 Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals
11/12/1998	WO1998050073A1 Integrin ligand, human mindin
11/12/1998	WO1998050072A1 Agent for treating tumoral diseases by removing b-lymphocytes from patients
11/12/1998	WO1998050066A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase
11/12/1998	WO1998050063A1 Method of treating hyperprolactinemia and prolactinomas
11/12/1998	WO1998050062A1 Compositions and methods of therapy for igf-i-responsive conditions
11/12/1998	WO1998050061A1 Novel therapies for cystic kidney disease
11/12/1998	WO1998050060A1 Therapies for acute renal failure
11/12/1998	WO1998050059A1 Method for preventing gastritis using amylin or amylin agonists
11/12/1998	WO1998050058A1 Complex formation between dsdna and oligomer of heterocycles
11/12/1998	WO1998050057A2 Agent for enhancing the heart force
11/12/1998	WO1998050054A1 Plant extracts for the treatment of increase bone resorption
11/12/1998	WO1998050050A1 Covalently linked n,o-carboxymethylchitosan and uses thereof
11/12/1998	WO1998050048A1 Aplidine as an l-type calcium channel enhancer
11/12/1998	WO1998036074A3 Single and double chain antibodies to the egf receptor, derivates thereof and their use
11/12/1998	WO1998036061A3 Reducing fibrosis and/or scarring by inhibiting interleukin-6 receptor-mediated activity
11/12/1998	WO1998032858A3 Mammalian chemokines; receptors; reagents; uses
11/12/1998	WO1998032846A3 Enzymatic nucleic acid treatment of diseases or conditions related to levels of c-fos
11/12/1998	WO1998032457A3 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
11/12/1998	WO1998031806A3 Fc receptors and polypeptides
11/12/1998	WO1998030255A3 Localized intravascular delivery of antioxidant substances for inhibition of restenosis in recanalized blood vessels
11/12/1998	WO1998029540A3 RECOMBINANT FUSION PROTEINS BASED ON RIBOSOME-INACTIVATING PROTEINS OF EUROPEAN MISTLETOE $i(VISCUM ALBUM)
11/12/1998	WO1998020030A3 Disruption of the mammalian rad51 protein and disruption of proteins that associate with mammalian rad51 for hindering cell proliferation
11/12/1998	WO1997039128A3 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
11/12/1998	CA2703181A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
11/12/1998	CA2702750A1 A novel strain of bacillus for controlling plant diseases and corn rootworm
11/12/1998	CA2618690A1 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
11/12/1998	CA2299455A1 Complex formation between dsdna and oligomer of heterocycles
11/12/1998	CA2289548A1 Method for preventing gastritis using amylin or amylin agonists
11/12/1998	CA2289125A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase
11/12/1998	CA2289123A1 Therapies for acute renal failure
11/12/1998	CA2289118A1 Novel tumor antigens
11/12/1998	CA2289115A1 Recombinant antibody-enzyme fusion proteins
11/12/1998	CA2289025A1 Human serine protease precursor
11/12/1998	CA2289010A1 Protease inhibitors
11/12/1998	CA2288982A1 Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals
11/12/1998	CA2288946A1 Modified antisense nucleotides complementary to a section of the human ha-ras gene
11/12/1998	CA2288806A1 Complex formation between dsdna and oligomer of heterocycles

1 ... 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 ... 3163